Federal Prosecutor Warns Locally Approved Medical Marijuana Dispensary It ‘May Subject To Criminal Prosecution’
From toxifillers.com with love
A U.S. attorney on Friday warned a locally approved medical marijuana dispensary about potential violations of federal law, suggesting it could face prosecution by the Trump administration’s Justice Department.
“Your dispensary appears to be operating in violation of federal law, and the Department of Justice has the authority to enforce federal law even when such activities may be permitted under state or local law,” says a letter from Edward R. Martin Jr, U.S. attorney for the District of Columbia, to the owners and operators of Green Theory, located in the Palisades neighborhood of Washington, D.C.
“Persons and entities owning, operating, or facilitating such dispensaries (as well as premises grow centers),” it adds, “may be subject to criminal prosecution and civil enforcement actions under federal law.”
Beyond merely possessing and distributing marijuana, the letter says Green Theory “appears to be operating within 1,000 feet of several schools, including: Our Lady of Victory Catholic School; the River School; St. Patrick’s Episcopal Day School; the Lab School; and Little Ivies preschool.”
It notes that “enhanced federal penalties may apply when a dispensary is operating within 1,000 feet of a school.”
The letter requests a response by May 12 with answers to three questions:
- Are you aware of the federal laws related to marijuana dispensaries and their locations near schools?
- Have you addressed these issues with federal law enforcement officials?
- Can you produce documentation regarding your compliance with federal law?
“I am concerned that you are in violation of federal laws,” Martin wrote, “which are intended to protect children. To that end, the need to address this issue is serious.”
The letter is addressed to Green Theory operators Johnathan Crandall, Robert Martin and Ian Tsang.
Perhaps crucial to the dispute, a federal budget rider is intended to prevent the Department of Justice from using funds to interfere with state medical marijuana programs. The so-called Rohrabacher–Farr amendment, named after the lawmakers who sponsored it, prohibits DOJ from spending money “to prevent [states with legal medical marijuana] from implementing their own laws that authorize the use, distribution, possession, or cultivation of medical marijuana.”
Green Theory’s Palisades dispensary has been at the center of neighborhood controversy of late, with residents and child safety advocates protesting its location near five private schools. The letter from Martin, an appointee of President Donald Trump, is the latest salvo in the matter.
It “sounds like an awesome business, just not in a corridor of so many young children,” Jackie Puente, who helped establish the advocacy group 1,000 Feet—which takes its name from the federal law creating drug-free zones around schools—told Axios D.C.
Green Theory was reportedly one of the first in D.C. to transition from being an illicit so-called “gifting shop”—which attempted to use a loophole to sell non-regulated marijuana to adults—to become part of the District’s licensed medical marijuana program.
The dispensary at one point sought to allow onsite marijuana use, with a business plan that envisioned “a vibe similar to the world-famous Amsterdam Coffee Shops.” Since then, however, co-founder Martin said the business no longer intends to allow onsite consumption.
Under D.C.’s own cannabis rules, dispensaries can’t operate within 300 feet of schools, though commercially zoned areas—where schools may be located—are exempt.
In a March 2024 letter, the District’s Alcoholic Beverage and Cannabis Administration (ABCA) argued federal law does not interfere with its medical marijuana program, which the agency said had “been subject to congressional review, and has not been disapproved or repealed.”
Regarding the Rohrabacher–Farr budget provision, ABCA wrote in the letter, “It is well established that cannabis is federally illegal, and that persons and entities may be subject to federal controlled substance laws. Nevertheless, Congress has also decided to repeatedly enact a budget rider protecting the District’s and other state’s medical cannabis programs that are currently in effect.”
The Outlaw Report, which covers cannabis news in the Washington, D.C. region, points out that the disagreement over Green Theory’s location issue “does highlight D.C.’s lack of real estate, forcing schools, liquor stores and dispensaries into commercial zones.”
Late last month, meanwhile, the White House called the District’s move to decriminalize marijuana an example of a “failed” policy that “opened the door to disorder.”
In a fact sheet about an executive order that Trump signed on Friday—which is broadly aimed at beautifying the District and making it more safe—the White House listed several local policies in the nation’s capital that it takes issue with, including cannabis reform. That’s despite the president’s previously stated support for a states’ rights approach to marijuana laws.
“D.C.’s failed policies opened the door to disorder—and criminals noticed,” it says, citing “marijuana decriminalization,” as well as the District’s decision to end pre-trial detentions and enforcement practices around rioters, as examples of such policies.
The executive order itself doesn’t mention marijuana specifically. But it says the directive will involve “deploying a more robust Federal law enforcement presence and coordinating with local law enforcement to facilitate the deployment of a more robust local law enforcement presence as appropriate in areas in or about” D.C., and that includes addressing “drug possession, sale, and use.”
Recreational cannabis possession and personal cultivation is legal in D.C. under a voter-approved ballot initiative, though commercial sales of non-medical marijuana remain illegal.
Because of a different congressional rider that’s been renewed annually since that vote, the District hasn’t been able to use its local funds to implement a system of regulated recreational cannabis sales, so officials have taken steps to expand the city’s existing medical marijuana program as a workaround.
During Trump’s first term, he maintained that D.C. rider to keep blocking cannabis sales in his budget requests, as did his successor, former President Joe Biden.
But as advocates and industry stakeholders have waited to see how the Trump administration will navigate cannabis policy issues during this second term—and whether the president will push for reforms such as rescheduling and banking access as he endorsed on the campaign trail—the fact his White House’s first public mention of marijuana in its D.C.-focused fact sheet linked decriminalization to disorder sent a different message.
Now, the new letter from the U.S. attorney raises new questions about the Justice Department’s stance on cannabis under Trump.
Meanwhile this week, an activist who received a pardon for a marijuana-related conviction during Trump’s first term paid a visit to the White House, discussing future clemency options with the recently appointed “pardon czar.”
Separately, a marijuana industry-backed political action committee (PAC) has released a series of ads over recent weeks that have attacked Biden’s cannabis policy record as well as the nation of Canada, promoting sometimes misleading claims about the last administration while making the case that Trump can deliver on reform.
Its latest ad accused Biden and his Drug Enforcement Administration (DEA) of waging a “deep state war” against medical cannabis patients—but without mentioning that the former president himself initiated the rescheduling process that marijuana companies want to see completed under Trump.
Adding uncertainty to that process, Trump’s pick to lead DEA, Terrance Cole, is on record repeatedly voicing concerns about the dangers of marijuana and linking its use to higher suicide risk among youth.
The current acting administrator, Derek Maltz, has separately made a series of sensational claims about marijuana, calling it a gateway drug that sets children up to use other substances, suggesting marijuana use is linked to school shootings and alleging that the Justice Department “hijacked” the cannabis rescheduling process from DEA.
Earlier this month, DEA notified an agency judge that the marijuana rescheduling process is still on hold—with no future actions currently scheduled as the matter sits before Maltz.
Meanwhile, a recent poll found that a majority of Republicans back a variety of cannabis reforms. And notably, they’re even more supportive of allowing states to legalize marijuana without federal interference compared to the average voter.
The survey showed that majorities of overall voters (70 percent) and GOP voters (67 percent) back rescheduling cannabis.
The survey was first noted by CNN in a report last month that quoted a White House spokesperson saying the administration currently has “no action” planned on marijuana reform proposals, including those like rescheduling and industry banking access that Trump endorsed on the campaign trail last year.
The White House has also said that marijuana rescheduling is not a part of Trump’s drug policy priorities for the first year of his second term—a disappointment for advocates and stakeholders who hoped to see him take speedier action.
Meanwhile, former marijuana prisoners who received clemency from Trump during his first term staged an event outside the White House last week, expressing gratitude for the relief they were given and calling on the new administration to grant the same kind of help to others who are still behind bars for cannabis.
Insurance Companies Are Not Required To Cover Medical Marijuana, Federal Judge Rules
The post Federal Prosecutor Warns Locally Approved Medical Marijuana Dispensary It ‘May Subject To Criminal Prosecution’ appeared first on Marijuana Moment.